Indo-Bangla Pharmaceuticals Limited (DSE:IBP)

DSE:IBP Ratios and Metrics

Market cap in millions BDT. Fiscal year is July - June.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 31, 2025	Jun 30, 2024	Jun 30, 2023	Jul 1, 2022	Jul 1, 2021	Jun 30, 2020
Market Capitalization	1,313	1,546	1,975	2,036	2,186	2,230
Market Cap Growth	17.71%	-21.77%	-2.97%	-6.88%	-1.96%	-7.22%
Enterprise Value	1,328	1,570	2,047	2,079	2,262	2,167
Last Close Price	11.30	13.29	16.98	17.78	18.70	18.63
PE Ratio	-	-	234.98	80.87	16.23	14.27
PS Ratio	14.41	8.75	5.28	4.20	2.80	2.58
PB Ratio	0.84	0.98	1.22	1.25	1.35	1.47
P/TBV Ratio	0.84	0.98	1.22	1.25	1.35	1.47
P/FCF Ratio	-	65.38	46.03	42.77	-	-
P/OCF Ratio	95.44	45.77	27.08	23.33	14.48	12.71
EV/Sales Ratio	14.58	8.89	5.47	4.29	2.89	2.50
EV/EBITDA Ratio	-	328.22	30.53	27.74	10.81	9.00
EV/EBIT Ratio	-	-	71.35	58.07	13.05	10.23
EV/FCF Ratio	-	66.42	47.69	43.67	-	-
Debt / Equity Ratio	0.01	0.02	0.03	0.05	0.05	-
Debt / EBITDA Ratio	-	5.06	0.65	1.01	0.41	-
Debt / FCF Ratio	1.45	1.02	1.02	1.58	-	-
Asset Turnover	0.05	0.10	0.20	0.26	0.43	0.52
Inventory Turnover	0.50	0.92	1.55	1.76	2.39	2.65
Quick Ratio	2.24	2.12	1.88	1.61	1.65	1.89
Current Ratio	5.27	4.95	4.26	3.50	3.57	4.82
Return on Equity (ROE)	-2.90%	-2.56%	0.52%	1.55%	8.57%	10.80%
Return on Assets (ROA)	-1.02%	-0.80%	0.95%	1.18%	5.95%	7.96%
Return on Capital (ROIC)	-1.16%	-0.91%	1.06%	1.31%	6.71%	9.16%
Return on Capital Employed (ROCE)	-	-	1.60%	2.10%	10.00%	13.10%
Earnings Yield	-3.50%	-2.65%	0.43%	1.24%	6.16%	7.01%
FCF Yield	-	1.53%	2.17%	2.34%	-2.26%	-5.99%
Dividend Yield	0.09%	0.07%	-	0.56%	2.14%	-
Payout Ratio	-	-	123.72%	98.46%	19.97%	8.49%
Buyback Yield / Dilution	-28.19%	-	-	-2.17%	-	-13.37%
Total Shareholder Return	-28.11%	0.07%	-	-1.61%	2.14%	-13.37%

Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.